KN40_H1H4

Size: px
Start display at page:

Download "KN40_H1H4"

Transcription

1 NOV 2015

2 01

3 Straight Expanded Thread Lead Pitch Tap 02

4 03

5 Chambrone L, Mandia J, Shibli JA, Romito GA, Abrahao M. Dental implants installed in irradiated jaws: a systematic review. J Dent Res 2013; 92(12 Suppl): 119S-130S. Yamazaki M, Inukai M, Baba K, Jhon MT. Japanese version of the Oral Health Impact Profile (OHIP-J). J Oral Rehabil (3): Stoumpis C and Kohal RJ. To splint or not to splint oral implants in the implant-supported overdenture therapy? A systematic review. J Oral Rehabil. 38(11): Shimmel M, Srinivasan M, Herrmann FR, Müller F. Loading protocols for implant-supported overdentures in the edentulous jaw: a systematic review and meta-analysis. Int J Oral Maxillofac Implants. 29 Suppl Gallucci GO, Benic GI, Eckert SE, Papaspyridakos P, Schimmel M, Schrott A, Weber HP. Consensus statements and clinical recommendations for implant loading protocol. Int J Oral Maxillofac Implants. 29 Suppl Dawson A and Chen S. The SAC classification in Implant Dentistry. Quintessence Publishing Wismeijer D, Casentini P, Gallucci G, Chiapasco M. ITI Treatment Guide volume4. Quintessence Publishing Cakarer S, Can T, Yaltirik M, Keskin C. Complications associated with the ball, bar and Locator attachments for implant-supported overdentures. Med Oral Pathol Oral Cir Bucal. 16(7): e953-e959,

6 Switch on EMINEO Fixture Line-up NP RP WP 05

7 06

8 Colloquium in

9 08

10 09

11 10

12

ITI International Team for Implantology Straumann

ITI International Team for Implantology Straumann ベーシックインフォメーション SURGICAL PROCEDURES Straumann Dental Implant System ITI International Team for Implantology Straumann 1. Straumann 1.1 1.2 1.2.1 Straumann 1.2.2 Straumann 1.2.3 Straumann 1.2. Straumann

More information

Technical Information ベーシックインフォメーション SURGICAL PROCEDURES Straumann Dental Implant System

Technical Information ベーシックインフォメーション SURGICAL PROCEDURES Straumann Dental Implant System Technical Information ベーシックインフォメーション SURGICAL PROCEDURES Straumann Dental Implant System ITI International Team for Implantology Straumann 1. Straumann 1.1 1.2 1.2.1 Straumann 1.2.2 Straumann 1.2.3 Straumann

More information

Flyer_SLActive_01【Q下げ】.indd

Flyer_SLActive_01【Q下げ】.indd Straumann SLActive 3 4 * 1 9 1, 2, 3 au 7000 6000 5000 4000 3000 2000 1000 0 ( 10 SEM ) 3 10 3 * 2 4,5 60 50 40 30 20 10 0 1 % 5 2 4 3 6 6 in vitro 3 BIC 24 7 70 % 60 % 50 % 40 % 30 % 20 % 10 % 0 % 1 2

More information

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ 29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27

More information

橡ボーダーライン.PDF

橡ボーダーライン.PDF 1 ( ) ( ) 2 3 4 ( ) 5 6 7 8 9 10 11 12 13 14 ( ) 15 16 17 18 19 20 ( ) 21 22 23 24 ( ) 25 26 27 28 29 30 ( ) 31 To be or not to be 32 33 34 35 36 37 38 ( ) 39 40 41 42 43 44 45 46 47 48 ( ) 49 50 51 52

More information

A B A E

A B A E 10533-68-3955 10533-68-3955 10533-68-3804 RP A-6 10533-68-3804 10533-69-9615 10533-57-2161 B-2 10533-68-2274 10533-68-2221 10533-67-6282 A-6 10533-57-2161 E-3 10533-68-5161 10533-68-3553 D-2 D-2 10533-69-5258

More information

.T.C.Y._.E..

.T.C.Y._.E.. 25 No.33 C O N T E N T S REVIEW 1 2 5 4 3 6 7 8 9 1 11 1, 1, 7,5 75 916,95 (121) 756,67 (15) 718,89 (13) 91,496 (169) 54,2 (179) 3,243 (75) 727,333 (129) 564,47 (112) 55,458 (11) 6,68,953 (18) 5,624,957

More information

FR 34 316 13 303 54

FR 34 316 13 303 54 FR 34 316 13 303 54 23 ( 1 14 ) ( 3 10 ) 8/4 8/ 100% 8 22 7 12 1 9 8 45 25 28 17 19 14 3/1 6/27 5000 8/4 12/2930 1 66 45 43 35 49 25 22 20 23 21 17 13 20 6 1 8 52 1 50 4 11 49 3/4/5 75 6/7/8 46 9/10/11

More information

P000.\...ai

P000.\...ai 2007.11 http://www.tateyama-advance.co.jp/ PRODUCTS LINEUP P5 P9 P13 WH WH WH WH WH WH WH WH WH WH WH WH WH WH WH WH 5 6 WH WH WH WH WH WH WH WH WH WH WH WH WH S WH 7 8 WH WH WH WH WH WH WH WH WH WH WH

More information

SLActive_cs4.indd

SLActive_cs4.indd SIMPLY BETTER STRAUMANN SLActive SLActive 1 SLActive SLA SLActive SLA 2,3,4,5,6,7 SLActive 1,3,4,5,6,7,8,9 3 4 2 8 SLActive SLA SLActive SLA 1 2 3 4 5 6 7 8 1,2 SLActive 2 2 4 1 SLActive SLA SLActive 11

More information

untitled

untitled 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0 18.5 18 60.4 6.3 45.5 18.9 41.8 5.0 29.3 17.1 1.2 3.7 0.0 0.0 1.5 19 20 21 22 2.50 2.00 1.50 1.00 0.50 0.00 19 2.38 1.48 1.02 2.05 0.11 0.00 0.00 20 21 1.22 0.44

More information

Version C 1 2 3 4 5 1 2 3 4 5 6 7 8 9 0 A 1 2 1 3 4 5 1 1 2 1 1 1 2 4 5 6 7 8 3 1 2 C a b c d e f g A A B C B a b c d e f g 3 4 4 5 6 7 8 1 2 a b 1 2 a b 1 2 1 2 5 4 1 23 5 6 6 a b 1 2 e c d 3

More information

Straumann Roxolid More than solid Roxolid.

Straumann Roxolid More than solid Roxolid. Straumann Roxolid More than solid Roxolid. More than a less invasive solution. 1 2 2 Straumann Roxolid 9 More than solid. Roxolid. Roxolid 3,4 5,6,7 Roxolid 24% 11mm F 30 3mm 250 310 Straumann TiGr4 cold

More information

324.pdf

324.pdf 50 50 10 30 11 26 12 27 14 16 27 18 20 21 22 22 22 22 23 24 24 1 No.324 JA 2 85 69 20 12 81 18 12 22 93 10 31 3 50 50 30 30 50 22 27 27 10 16 14 52 10 62 15 64 25 24 50 4 25 23 27 5 10 11 25 6 11 49 10

More information

『こみの株式会社』の実践

『こみの株式会社』の実践 2003 . JA JA A JA 811 2005/8/11 1003 452 10 960 28 2005/8/11 1003 452 6 120 29 2005/8/11 2003 151 10 420 33 2005/8/11 2003 211 3 180 31 2005/8/11 2003 211 3 150 32 827 400 5 80 221 2005/6/25 900 3 300

More information

15 7 26 1,276 3,800 1 16 15 1 2 3 4 2

15 7 26 1,276 3,800 1 16 15 1 2 3 4 2 1 15 7 26 1,276 3,800 1 16 15 1 2 3 4 2 JA 3 4 2 1 3 2001 1981 6 10% 10 30% 1 2 JA JA 2 4 JA 2 1 2 1 2 1 2 1 2 1 2 7 5 1 1 1 3 1 6 1 1 2 2 1 7 2 3 3 53 1 2000 30 8 250 53 435 20 35 3 1 8 2 4 3 2 2 232

More information

EX-word_Library_JA

EX-word_Library_JA JA 2 3 4 5 14 7 1 2 6 3 1 2 7 3 8 27 1 2 3 1 2 3 9 1 2 3 1 2 3 10 12 13 14 11 1 12 1 2 13 1 2 3 25 14 1 2 3 25 15 1 2 3 25 16 1 2 3 25 17 1 2 3 25 18 1 2 3 4 25 19 1 2 3 4 25 20 1 2 21 3 4 25 22 1 2 3

More information

<322E20D8CCDFDAB2BDBEDAB8C4A5C3B0CADFB0C4DEA4C9B0CDDED9D8CCDFDAB2BDA5C3B0CADFB0C4DEA5B8DED9B0CBDEB E706466>

<322E20D8CCDFDAB2BDBEDAB8C4A5C3B0CADFB0C4DEA4C9B0CDDED9D8CCDFDAB2BDA5C3B0CADFB0C4DEA5B8DED9B0CBDEB E706466> / 3 1 6 / 2 4 6 8 10 11 12 16 17 23 24 27 28 29 32 34 46 51 54 60 62 66 67 68 73 4 / / 2 mm / 2 mm 3.5 mm 3.5 mm 4.3 mm 3.5 mm 4.3 mm 5.0 mm 3.5 mm 4.3 mm 5.0 mm 6.0 mm 3.5 mm 4.3 mm 5.0 mm 6.0 mm / /

More information

STRAUMANN SLA サーフェイス 長期的成功のためのゴールドスタンダード優れた 10 年間の治療成績を誇る表面性状技術 インプラントの表面構造は 良好なオッセオインテグレーションの達成において重要な要素です ストローマンの SLA サーフェイスは 長期的なオッセオインテグレーションの獲得によ

STRAUMANN SLA サーフェイス 長期的成功のためのゴールドスタンダード優れた 10 年間の治療成績を誇る表面性状技術 インプラントの表面構造は 良好なオッセオインテグレーションの達成において重要な要素です ストローマンの SLA サーフェイスは 長期的なオッセオインテグレーションの獲得によ CONFIDENCE AT BONE LEVEL 骨レベルにおける信頼性 Featuring SLA surface! STRAUMANN SLA サーフェイス 長期的成功のためのゴールドスタンダード優れた 10 年間の治療成績を誇る表面性状技術 インプラントの表面構造は 良好なオッセオインテグレーションの達成において重要な要素です ストローマンの SLA サーフェイスは 長期的なオッセオインテグレーションの獲得により治癒期間の短縮を実現し

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション 光殺菌治療について 当院が実施する体に優しい光殺菌治療のご案内 FotoSan 630 光殺菌治療とは? 感染部分に光感受性物質を注入し 光を照射することで殺菌する安全な治療法です 医科では早期がんの治療法として 医科では1990 年ごろから光やレーザーを用いて 肺 食道 胃 子宮頸部などの早期がんに対して治療を行う光線力学療法 (PDT=Photo-Dynamic Therapy) という治療法があります

More information

2

2 ( ) 1 1 2 3000 2500 2000 1500 1000 500 0-500 -1000-1500 18 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 3 3 1980 ( ) 1980 43 87 33 10 10 2001 80 07 58.6

More information

94.7 H22 H22 140,000 120,000 3.31 3.24 3.02 2.85 116,435 122,529 126,317 3.5 3 100,000 80,000 77,498 93,159 105,099 112,878 2.73 2.62 2.51 2.5 2 60,000 40,000 20,000 23,412 28,790 34,786 39,571

More information

untitled

untitled P125(2) ()()()() ()()() ()()()()()()() 1 - - - - - - - - - - - - - - -1 - - - 105 105 105120 105120 105120 105120 105120 90 90 90 90 90 105 105 105 105 105120 105120 105120 105120 90 90 90 90 85 85 85

More information

Taro12-第4回意見募集結果(改訂

Taro12-第4回意見募集結果(改訂 - - - - - - - - - - - - - - HP - - - - - - - - - - - - - - -

More information

平成16年度外務省事後評価実施計画策定について

平成16年度外務省事後評価実施計画策定について 2005 1 HP http://www.mofa.go.jp/mofaj/area/n_korea/index.html http://www.mofa.go.jp/mofaj/area/n_korea/abd/rachi_mondai.html HP http://www.mofa.go.jp/mofaj/area/n_korea/abd/6kaigo3_gh.html http://www.mofa.go.jp/mofaj/press/danwa/17/dga_0414b.html

More information

2 4 5 6 7 8 9 HP 10 11 12 14 15 , 16 17 18 19 20 21 22 24 25 26 27 28 29 30 31 34 35 36 37 38 39, 40 41 42 43 44 45 46 47 48 49 50 51 52 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 1 70 71 72

More information

80期期末_表1_web.ai

80期期末_表1_web.ai 80 01 TO OUR SHAREHOLDERS 01 01 02 05 11 12 13 14 Go! Next 60 02 Go! Next 60 03 04 Go! Next 60 TOPICS 05 TOPICS 06 TOPICS 07 TOPICS 08 TOPICS 09 10 TOPICS FINANCIAL REVIEW 2,978 3,054 3,264 387 379 421

More information

untitled

untitled 186 17 100160250 1 10.1 55 2 18.5 6.9 100 38 17 3.2 17 8.4 45 3.9 53 1.6 22 7.3 100 2.3 31 3.4 47 OR OR 3 1.20.76 63.4 2.16 4 38,937101,118 17 17 17 5 1,765 1,424 854 794 108 839 628 173 389 339 57 6 18613

More information

untitled

untitled 1. 3 14 2. 1 12 9 7.1 3. 5 10 17 8 5500 4. 6 11 5. 1 12 101977 1 21 45.31982.9.4 79.71996 / 1997 89.21983 41.01902 6. 7 5 10 2004 30 16.8 37.5 3.3 2004 10.0 7.5 37.0 2004 8. 2 7 9. 6 11 46 37 25 55 10.

More information

巻頭言・目次(CS2).indd

巻頭言・目次(CS2).indd Journal of Oral Health and Biosciences 臨 床 指 導 講 演 キーワード:Obstructive sleep apnea syndrome, Oral appliance, Bite-jumping appliance Oral Appliance for Treatment of Obstructive Sleep Apnea Syndrome Keisuke

More information

1

1 1 2 3 4 5 0% 20% 40% 60% 80% 100% 6 7 8 0% 20% 40% 60% 80% 100% 9 0% 20% 40% 60% 80% 100% 10 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 2529 (n=17) 3034 35 (n=21) (n=17) 2529 (n=19) 3034 35 (n=34) (n=64)

More information

A Clinical Study on Dental CAD/CAM CEREC(R) System Fitness of CEREC(R) Porcelain Laminate Veneers-- Takashi Nakamura, Yutaka Tanaka*, Hiroyuki Ogawa,

A Clinical Study on Dental CAD/CAM CEREC(R) System Fitness of CEREC(R) Porcelain Laminate Veneers-- Takashi Nakamura, Yutaka Tanaka*, Hiroyuki Ogawa, A Clinical Study on Dental CAD/CAM CEREC(R) System Fitness of CEREC(R) Porcelain Laminate Veneers-- Takashi Nakamura, Yutaka Tanaka*, Hiroyuki Ogawa, Takeshi Akao, Aogu Imanishi, Toshizumi Hino and Takao

More information

表紙PDF作成用/PDF表紙作成用

表紙PDF作成用/PDF表紙作成用 200 Vol.51 No.2 Jpn J School Health Jpn J School Health Graduate School of Education, Okayama University Jpn J School Health Jpn J School Health p p p p p p p pp p p p p p p p p p p p ppp Jpn J School

More information

_...C44

_...C44 J Health Care Dent. 2007; 9: 4-23 Printed in Japan. All rights reserved * Report of Dr. Mituhiro Tsukiboshi s Lecture Meeting Minimal Intervention Dentistry to Think about The Lifetime Health of the Patients

More information

EBM Reviews Ovid Ovid EBM Reviews ACP Journal Club Cochrane Database of Systematic Revie

EBM Reviews Ovid   Ovid EBM Reviews ACP Journal Club Cochrane Database of Systematic Revie EBM Reviews 2006 4 Ovid http://www.usaco.co.jp/products/ovid/ovidplatform.html Ovid EBM Reviews ACP Journal Club Cochrane Database of Systematic Reviews CDSR Database of Abstracts of Reviews of Effectiveness

More information

明海大学歯学雑誌 36‐2/11.黒岩

明海大学歯学雑誌 36‐2/11.黒岩 J Meikai Dent Med 362, 153 160, 2007 153 X X X 0.5 mm 2mm X X 0.91.0 6.93 mm 6.93 mm 20 mm 9.5 10.4 30 mm 6.3 6.9 X Radiological Study for Implant Preoperative Diagnosis Geometric Accuracy of Panoramic

More information

A Study on Dento-Facial Morphology in Maxillary Protrusion Yousuke Kuwahara Department of Orthodontics, School of Dentistry, Tokyo Medical and Dental

A Study on Dento-Facial Morphology in Maxillary Protrusion Yousuke Kuwahara Department of Orthodontics, School of Dentistry, Tokyo Medical and Dental A Study on Dento-Facial Morphology in Maxillary Protrusion Yousuke Kuwahara Department of Orthodontics, School of Dentistry, Tokyo Medical and Dental University. (Director : Prof. Fujio Miura) 1)

More information

( )

( ) ( ) ( 27) ( 28) ( ) 170ha 62 ょ - 1 - ( ) 50-2 - ( ) JA - 3 - ( ) - 4 - ( ) - 5 - ( ) - 6 - ( ) HP - 7 - ( ) - 8 - ( ) ( ) - 9 - ( ) - 10 - ( ) - 11 - ( ) - 12 - ( ) - 13 - ( ) - 14 - ( ) 9 15 16 2,000

More information

Financial Statements 2004

Financial Statements 2004 Financial Statements 2004 10,150 5,591 $ 92,227 16,078 13,561 146,100 463 462 4,205 193 205 1,758 915 607 8,317 1,202 1,088 10,918 (80) (83) (726) 28,921 21,431 262,799 1,435 927 13,035 657 656 5,964 537

More information

9 WHO 89,, TD 8, km Beth Damgkor Beth Meas Samrong Angkor Wat Svay Chra Mok Chrouk Wat Svay Wat Chak 7,7 8 7,7 8 9 χ

9 WHO 89,, TD 8, km Beth Damgkor Beth Meas Samrong Angkor Wat Svay Chra Mok Chrouk Wat Svay Wat Chak 7,7 8 7,7 8 9 χ 8 : 8 8, 7 9. 99. 97.dft DMFT dft 9., dft., DMFT.8 Key words 97 979 99 99 ODA NGO 78 78 78 9 98 98, 7 7 Auxiliary Dentist 99 7 7 Traditional Dentist TD TD, 8, 9 8 9 WHO 89,, TD 8, km Beth Damgkor Beth

More information

! 1Munderl P et al. Survival and causes of death, 2 years after Introduction of antiretroviral therapy in Africa. XVI International AIDS Conference, 2006, Abstract THLB0208. 2Walensky RP et al. The

More information

02

02 54 163116831 02 1 168 54 158 53 162 53 148 52 152 52 10,000 0 40,000 30,000 20,000 50,000 70,000 60,000 1,000 500 1,500 2,000 0 2,500 3,000 4,000 3,500 4,500 168 54 158 53 162 53 148 52 152 52 03 52148

More information

untitled

untitled 1 2 3 4 5 6 7 8 9 10 40% 2000 11 12 13 o o o o o o v v o v v v o v o v o o o o o o o o o o o o v o o o o o v o o v o o v v o o v o o v o o v o o o o o v o o o o o o o o o v 14 15 1980 16 17 18 19 20 8013%

More information

眼科領域アレルギー性疾患に対する診断と治療

眼科領域アレルギー性疾患に対する診断と治療 57 4 213 220 2014 1 2 3 1. allergic conjunctival disorders ACD 1 allergic conjunctivitis AC 2 seasonal allergic conjunctivitis SAC perennial allergic conjunctivitis PAC atopic keratoconjunctivitis AKC

More information

Core Ethics Vol. Epstein, CI CI CI CI CI CI CI CI Epstein, CI CI CI CI CI CI CI CI CI CI Schindler, CI CI CI CI NIH CI Finn FDA / M CI N CI N / M, CI

Core Ethics Vol. Epstein, CI CI CI CI CI CI CI CI Epstein, CI CI CI CI CI CI CI CI CI CI Schindler, CI CI CI CI NIH CI Finn FDA / M CI N CI N / M, CI Core Ethics Vol. Cochlear Implant CI,, CI CI,,, CI CI CI CI CI, CI CI CI CI CI CI CI CI CI CI CI CI CI Core Ethics Vol. Epstein, CI CI CI CI CI CI CI CI Epstein, CI CI CI CI CI CI CI CI CI CI Schindler,

More information

産業21-81号.72.indd

産業21-81号.72.indd 2015.7 81 http://www.rofuku.go.jp/tabid/128/default.aspx C O N T E N T S 21 2 6 8 10 12 16 18 20 22 24 26 27 28 29 211 221 1 213 421 215 2 621 217 821 3 219 1021 4 2111 1221 2113 1421 2115 1621 5 2117

More information

WEB CEF 1996 ( CEF) CLT CEF 2001 CLT CEF CLT CEF CEF CEF CEF

WEB CEF 1996 ( CEF) CLT CEF 2001 CLT CEF CLT CEF CEF CEF CEF CEF 1996 ( CEF) CLT CEF 2001 CLT 2003 5 2005 CEF 2006-07 CLT CEF CEF CEF CEF 1996 Common European Framework of Reference for Languages : Learning, teaching and assessment ( CEF) / Profile deutsch Niveau

More information

名称未設定-1

名称未設定-1 Study on Clinical Factors Affecting the Fungal Culture Test - Relevance of Dry Mouth - Yoshiko YAMAMURA, Yukihiro MOMOTA, Hideyuki TAKANO, Koichi KANI, Katsumi MOTEGI, Fumihiro MATSUMOTO, Masayuki AZUMA

More information

vol61_H1_H4_入校 のコピー.ai

vol61_H1_H4_入校 のコピー.ai A N G E volume 61 A N G E 1 2 3 4 59 3 news n e w s news volume.54 5 6 7 8 103 211 1225 112 13122 22343 110 214 21538 118 131 21 211 32122 329 137 31 110 124 228 328 1 118 211 116 216 216 222 308 2 124

More information

分科会(OHP_プログラム.PDF

分科会(OHP_プログラム.PDF 2B-11p 2B-12p 2B-13p 2B-14p 2B-15p 2C-3p 2C-4p 2C-5p 2C-6p 2C-7p 2D-8a 2D-9a 2D-10a 2D-11a 2D-12a 2D-13a 2E-1a 2E-2a 2E-3a 2E-4a 2E-5a 2E-6a 2F-3p 2F-4p 2F-5p 2F-6p 2F-7p 2F-8p 2F-9p 2F-10p 2F-11p 2F-12p

More information

05_学術.indd

05_学術.indd Arts and Sciences IMRT Optimal bladder volume in IMRT planning for prostate cancer 36076 51710 55385 46169 29333 Key words: Prostate cancer, IMRT, 3D-CRT, Treatment planning, Bladder volume summary As

More information

理学療法検査技術習得に向けた客観的臨床能力試験(OSCE)の試行

理学療法検査技術習得に向けた客観的臨床能力試験(OSCE)の試行 An Application of an Objective Structured Clinical Examination for Learning Skills in Assessment of Physical Therapy A Task Involving Measurements on the Range of Motion Test Chikako Fujita1) Hiroyasu

More information

Part y mx + n mt + n m 1 mt n + n t m 2 t + mn 0 t m 0 n 18 y n n a 7 3 ; x α α 1 7α +t t 3 4α + 3t t x α x α y mx + n

Part y mx + n mt + n m 1 mt n + n t m 2 t + mn 0 t m 0 n 18 y n n a 7 3 ; x α α 1 7α +t t 3 4α + 3t t x α x α y mx + n Part2 47 Example 161 93 1 T a a 2 M 1 a 1 T a 2 a Point 1 T L L L T T L L T L L L T T L L T detm a 1 aa 2 a 1 2 + 1 > 0 11 T T x x M λ 12 y y x y λ 2 a + 1λ + a 2 2a + 2 0 13 D D a + 1 2 4a 2 2a + 2 a

More information

E E E E E 9001700 113 114 0120-109217 E E E E E E E EE E E EE E E E E E E E E E E E E E E E E E E E E E E E E 9001700 113 114 0120-109217 9001700 113 114 0120-109217 E E E E E E E E E E

More information

SL-8号電話機 取扱説明書

SL-8号電話機 取扱説明書 E E E E E E 0120-109217 9001700 113 114 E E E E E E E E E E E E EE E E EE E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E 9001700 113 114 0120-109217 9001700 113

More information

26 1 : Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hira

26 1 : Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hira 26 1 : 35 45 2017 1 2 2 2 2 2 2 2 2 1 1 2 Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hirayama 1, Yoko Nakajo 2, Akemi Saito 2, Rie Hatakeyama

More information

™…{,

™…{, 57 th Annual Meeting of The Japanese Society of Child Health The 57th Annual Meeting of the Japanese Society of Child Health 3 4 The 57th Annual Meeting of the Japanese Society of Child Health 5 6 The

More information

名称未設定-1

名称未設定-1 Root coverage procedures Keiji OISHI, Toshihiko NAGATA Localized gingival recession and root exposure may cause an esthetic problem, root dentin hypersensitivity, root caries, and difficulties in plaque

More information

untitled

untitled 5 1.() 2.() 3.(JA ) 2 3 4 5 6 7 8 9 10 11 12 13 1,000m 165.52km2 1,200-1- H15.8.1 1,163 2,121 278 H19.2.1 60 12 8 15 13 4 10 14 4 13 15 16 22 16 12 21 44 81-2- - 0 - - 1 - - 2 - - 3 - - 4 -

More information

untitled

untitled 1993 2 2.1 2 1 200235 1992 6 7 3 3 84 JA 1990 47.3% 46.5% 1990 31.7% 56.9% 37 6 4 1976 2.2 2.2 1976 1974 1976 1981 1 3.5 1985 60 2005 2006 2006 27 103 522 284 3.5 3.6 2003 109 59.6% 54.1% 31.2% 1970

More information